Leading CMO purchases multiple GMP scale twin-column units
Continuous chromatography technology now planned for production suites to give CMO a leading edge with new therapies at attractive cost point. Patented MCSGP will significantly increase yield of oligo and peptide production.
Previous Article
FDA purchases YMC technology Related Posts
March 24, 2026
Revolutionizing Peptide Purification: A Blueprint for MCSGP Process Validation
The shift from batch to continuous manufacturing is a requirement in many biopharma applications, but regulatory compliance, specifically Process Validation, often remains a hurdle.
January 20, 2026
Join Us at Pittcon 2026
March 9-11, 2026 in San Antonio, TX
January 8, 2026
It’s hard to miss the pink lift on our construction site!
While it’s a vital tool helping us expand our facility by 50%, it carries a much deeper meaning. Our subcontractor found this lift and reconditioned it specifically to honor Anita Marchand, a beloved mother and grandmother who lost her life
